Literature DB >> 18528185

Prognostic value of initial fluorodeoxyglucose-PET in esophageal cancer: a prospective study.

Catherine Cheze-Le Rest1, Jean-Philippe Metges, Pierre Teyton, Véronique Jestin-Le Tallec, P Lozac'h, A Volant, D Visvikis.   

Abstract

OBJECTIVES: Esophageal cancer outcome greatly depends on the pathological stage. Our objectives were to assess prognosis on the basis of the initial fluorodeoxyglucose (FDG)-PET scan, focusing on the correlation between overall survival and FDG uptake in the primary, as well as the presence of FDG-positive lymph nodes or distant metastases.
METHODS: Fifty-two esophageal cancer patients undergoing FDG-PET as part of initial routine staging procedure before treatment were included. The maximum standardized uptake value (SUV max) was determined in each primary lesion and the number of abnormalities including primary, lymph nodes, or distant metastases was recorded. Correlation with overall survival was performed using Kaplan-Meier method and Cox regression analysis was used to assess the prognostic value of PET parameters.
RESULTS: Half of the patients were planned for initial curative surgery (52%). Using univariate survival analysis, either surgery, SUV max >9, two or more PET abnormalities or the presence of FDG-positive nodes were significant overall survival prognostic predictors. After multivariate analysis, only SUV max >9 and FDG-positive lymph nodes were found as independent predictors of poor outcome.
CONCLUSION: In this prospective study, FDG-PET was found to provide prognostic information supporting a new indication for initial FDG-PET examination in esophageal cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18528185     DOI: 10.1097/MNM.0b013e3282f81423

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  19 in total

1.  Accuracy of PET-CT in predicting survival in patients with esophageal cancer.

Authors:  Claire Brown; Ben Howes; Glyn G Jamieson; Dylan Bartholomeusz; Urs Zingg; Thomas R Sullivan; Sarah K Thompson
Journal:  World J Surg       Date:  2012-05       Impact factor: 3.352

2.  Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology.

Authors:  Mathieu Hatt; Dimitris Visvikis; Nidal M Albarghach; Florent Tixier; Olivier Pradier; Catherine Cheze-le Rest
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-03-02       Impact factor: 9.236

3.  Preoperative positron emission tomography/computed tomography predicts advanced lymph node metastasis in esophageal squamous cell carcinoma patients.

Authors:  Po-Kuei Hsu; Ko-Han Lin; Shyh-Jen Wang; Chien-Sheng Huang; Yu-Chung Wu; Wen-Hu Hsu
Journal:  World J Surg       Date:  2011-06       Impact factor: 3.352

4.  PET/CT predicts survival in patients undergoing primary surgery for esophageal cancer.

Authors:  Kirsten Lindner; Daniel Palmes; Norbert Senninger; Richard Hummel
Journal:  Langenbecks Arch Surg       Date:  2015-01-09       Impact factor: 3.445

5.  Diagnostic accuracy of ¹⁸F-FDG PET/CT for detection of suspected recurrence in patients with oesophageal carcinoma.

Authors:  Punit Sharma; Sachin Jain; Sellam Karunanithi; Sujoy Pal; Pramod Kumar Julka; Sanjay Thulkar; Arun Malhotra; Chandrasekhar Bal; Rakesh Kumar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-01-17       Impact factor: 9.236

6.  Positron emission tomography changes management and prognostic stratification in patients with oesophageal cancer: results of a multicentre prospective study.

Authors:  B E Chatterton; I Ho Shon; A Baldey; N Lenzo; A Patrikeos; B Kelley; D Wong; J E Ramshaw; A M Scott
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-10-18       Impact factor: 9.236

7.  Gastrointestinal 18F-FDG accumulation on PET without a corresponding CT abnormality is not an early indicator of cancer development.

Authors:  Till A Heusner; Steffen Hahn; Monia E Hamami; Un-Hi Kim; Rilana Baumeister; Michael Forsting; Alexander Stahl; Andreas Bockisch; Gerald Antoch
Journal:  Eur Radiol       Date:  2009-05-05       Impact factor: 5.315

8.  Use of positron emission tomography in surgery follow-up of esophageal cancer.

Authors:  P Teyton; J P Metges; A Atmani; V Jestin-Le Tallec; A Volant; D Visvikis; J P Bail; O Pradier; P Lozac'h; Catherine Cheze Le Rest
Journal:  J Gastrointest Surg       Date:  2008-11-21       Impact factor: 3.452

9.  Prognostic value of baseline FDG uptake on PET-CT in esophageal carcinoma.

Authors:  Omar S Al-Taan; Amar Eltweri; David Sharpe; Peter M Rodgers; Sukhbir S Ubhi; David J Bowrey
Journal:  World J Gastrointest Oncol       Date:  2014-05-15

10.  Maximum standardized uptake value in 18F-fluoro-2-deoxyglucose positron emission tomography is associated with advanced tumor factors in esophageal cancer.

Authors:  Takeshi Kajiwara; Yoichi Hiasa; Tomohiro Nishina; Toshihiko Matsumoto; Shinichiro Hori; Seijin Nadano; Haruo Iguchi; Satoru Takeji; Eiji Tsubouchi; Yoshio Ikeda; Morikazu Onji
Journal:  Mol Clin Oncol       Date:  2014-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.